Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
Nana Xu, Lei Wang, Chenxi Li, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 4, pp. 1554-1568
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 103
The oral microbiome and oral and upper gastrointestinal diseases
S Liu, Shidong Wang, Nan Zhang, et al.
Journal of Oral Microbiology (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Yun Chen, Boyuan Liu, Wei Yuan, et al.
Pharmacological Research (2021) Vol. 174, pp. 105966-105966
Closed Access | Times Cited: 45
Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment
Federica Pizzo, Zaira Maroccia, Ivano Hammarberg Ferri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6138-6138
Open Access | Times Cited: 32
Association of antibiotic use with risk of lung cancer: A nationwide cohort study
Minseo Kim, Sun Jae Park, Seulggie Choi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 7, pp. 1123-1130
Open Access | Times Cited: 16
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S46-S58
Closed Access | Times Cited: 7
Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial‐based therapeutics
Allan Radaic, Sean Ganther, Pachiyappan Kamarajan, et al.
Periodontology 2000 (2021) Vol. 87, Iss. 1, pp. 76-93
Open Access | Times Cited: 40
The composition of lung microbiome in lung cancer: a systematic review and meta-analysis
Sadaf Najafi, Fatemeh Abedini, Sadegh Azimzadeh Jamalkandi, et al.
BMC Microbiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 38
Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
Cátia Almeida, Rita Oliveira, Pilar Baylina, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2742-2742
Open Access | Times Cited: 25
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
Rajan Thapa, A Magar, Jesus Shrestha, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 5
Role of human microbiota in facilitating the metastatic journey of cancer cells
Himisa Shah, Premal H. Patel, Aritro Nath, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Bacterial infection and microbiota in carcinogenesis and tumor development
Qiao Li
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance
Andrew S. Bray, Christopher A. Broberg, Andrew W. Hudson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Gut microbiome and tumor immunotherapy
Mohini Vig, Shweta Dubey
International review of cell and molecular biology (2025)
Closed Access
Clinical characteristics and risk factors of late-stage lung adenocarcinoma patients with bacterial pulmonary infection and its relationship with cellular immune function
Kangli Yang, Haiting Wei, Weiwei Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Shafiul Haque, Ritu Raina, Nazia Afroze, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 666-681
Closed Access | Times Cited: 23
The microbiome of lung cancer tissue and its association with pathological and clinical parameters.
Ock‐Hwa Kim, Bo-Yun Choi, Dong Kwan Kim, et al.
PubMed (2022) Vol. 12, Iss. 5, pp. 2350-2362
Closed Access | Times Cited: 18
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
Megan O’Shaughnessy, Orla Sheils, Anne‐Marie Baird
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12296-12296
Open Access | Times Cited: 9
Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study
Xiaoxue Xia, Jiang Chen, Yiwen Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 14
A comparison of the microbiome composition in lower respiratory tract at different sites in early lung cancer patients
Kai Su, Yibo Gao, Jie He
Translational Lung Cancer Research (2023) Vol. 12, Iss. 6, pp. 1264-1275
Open Access | Times Cited: 8
Streptococcus australis and Ralstonia pickettii as Major Microbiota in Mesotheliomas
Rumi Higuchi, Taichiro Goto, Yosuke Hirotsu, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 4, pp. 297-297
Open Access | Times Cited: 18
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers
Zhu Liu, Lian‐Lian Hong, Zhi‐Qiang Ling
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16756-16773
Open Access | Times Cited: 7
Deciphering the impact of microbial interactions on COPD exacerbation: An in-depth analysis of the lung microbiome
Hamidreza Taherkhani, Azadeh KavianFar, Sargol Aminnezhad, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e24775-e24775
Open Access | Times Cited: 2
The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy
Yasmin Bano, Abhinav Shrivastava, Piyush Kumar Shukla, et al.
Critical Reviews in Microbiology (2024), pp. 1-25
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top